Clinical Trial

A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate the drug levels, safety and tolerability of BMS-986368 in healthy Chinese participants
Trial Details
NCT Number NCT07700329
Lead Sponsor Celgene
Conditions Healthy Volunteers
Enrollment 16 participants
Start Date 2027-01-05
Primary Completion 2027-02-23 (estimated)
Study Completion 2027-02-23 (estimated)
Updated on ClinicalTrials.gov 2026-07-14